abacavir and lamivudine
abacavir and lamivudine is listed in the FDA National Drug Code directory with 1 NDC code. Available dosage form: tablet, film coated.
Drug Details
- Generic Name
- abacavir and lamivudine
- Brand Names
- N/A
- Application Number
- Sponsor
- Aurobindo Pharma Limited
- NDC Codes
- 1
- Dosage Forms
- TABLET, FILM COATED
- Routes
- N/A
- Active Ingredients
- ABACAVIR SULFATE, LAMIVUDINE
Indications and Usage
1 INDICATIONS AND USAGE Abacavir and lamivudine tablets, in combination with other antiretroviral agents, are indicated for the treatment of human immunodeficiency virus type 1 (HIV-1) infection. Abacavir and lamivudine tablets, are combination of abacavir and lamivudine, both nucleoside analogue HIV-1 reverse transcriptase inhibitors, is indicated in combination with other antiretroviral agents for the treatment of HIV-1 infection. (1)